- Lower volatility than the market (beta 0.52)
- Highly efficient cash conversion (100% FCF/OCF ratio)
- Beat earnings estimates in 2 of the last 4 quarters
Pharmacyt Biotch stock upgraded from Sell Candidate to Buy Candidate after Thursday trading session
(Updated on Jul 02, 2026)
The Pharmacyt Biotch stock price fell by -3.51% on the last day (Thursday, 2nd Jul 2026) from $0.741 to $0.715. During the last trading day the stock fluctuated 7.69% from a day low at $0.715 to a day high of $0.770. The price has fallen in 6 of the last 10 days and is down by -9.17% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -5 thousand shares and in total, 55 thousand shares were bought and sold for approximately $39.33 thousand.
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.713 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.85% during the next 3 months and, with a 90% probability hold a price between $0.748 and $1.02 at the end of this 3-month period.
PMCB Signals & Forecast
There are mixed signals in the stock today. The Pharmacyt Biotch stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.751 and $0.769. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Friday, June 05, 2026, and so far it has risen 2.14%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Pharmacyt Biotch stock
Pharmacyt Biotch finds support from accumulated volume at $0.700 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0550 between high and low, or 7.69%. For the last week the stock has had daily average volatility of 7.49%.
Our recommended stop-loss: $0.672 (-5.99%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 18 days ago.)
Trading Expectations (PMCB) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Pharmacyt Biotch to open at $0.733, and during the day (based on 14 day Average True Range), to move between $0.686 and $0.744, which gives a possible trading interval of +/-$0.0571 (+/-8.32%) up or down from last closing price. If Pharmacyt Biotch takes out the full calculated possible swing range there will be an estimated 8.32% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.700 (2.10%) than the resistance at $0.790 (10.49%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Pharmacyt Biotch stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Pharmacyt Biotch stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score:
1.020
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on July 6, 2026 - $0.733 ( 2.56%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
PMCB Performance
Trading levels for PMCB
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.788 | 10.26% |
| R2 | 0.767 | 7.32% |
| R1 | 0.754 | 5.50% |
| Price | 0.715 | |
| S1 | 0.712 | -0.374% |
| S2 | 0.699 | -2.19% |
| S3 | 0.678 | -5.13% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.81 | 13.29% |
| R2 | 0.80 | 12.50% |
| R1 | 0.790 | 10.49% |
| Price | 0.715 | |
| S1 | 0.700 | -2.10% |
| S2 | 0.695 | -2.81% |
| S3 | 0.684 | -4.34% |
FAQ
Click here for our free guide on how to buy Pharmacyt Biotch Stock.
Buy PMCB